Related articles

  • Randomized Controlled Trial

    Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.

    Lancet Neurol. 2010 Jul 1;9(7):672-80.

  • Randomized Controlled Trial

    NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.

    Lancet Neurol. 2009 Jun 1;8(6):519-29.

  • Review

    Dimethyl fumarate for multiple sclerosis.

    Cochrane Db Syst Rev. 2015 Apr 22; 2015 (4): CD011076CD011076.

    • Show more related articles...